Quick Answer
Fulgent Genetics, Inc. reported Operating Income Loss of -$91.10 million for the year ending 2025.
- Fulgent Genetics, Inc. showed a decrease of -23.2% in Operating Income Loss from 2024 to 2025.
- This data is from Fulgent Genetics, Inc.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2015: $405.0 thousand | Q2 2015: $747.0 thousand | Q3 2015: $1.18 million | Q4 2015: -$7.34 million | Q1 2016: -$615.0 thousand | Q2 2016: $970.0 thousand | Q3 2016: -$695.0 thousand | Q4 2016: $1.26 million | Q1 2017: $219.0 thousand | Q2 2017: -$150.0 thousand | Q3 2017: -$1.48 million | Q4 2017: -$2.07 million | Q1 2018: -$2.19 million | Q2 2018: -$1.00 million | Q3 2018: -$846.0 thousand | Q4 2018: -$1.03 million | Q1 2019: -$1.82 million | Q2 2019: $295.0 thousand | Q3 2019: $1.51 million | Q4 2019: -$409.0 thousand | Q1 2020: -$1.91 million | Q2 2020: $2.64 million | Q3 2020: $63.52 million | Q4 2020: $225.91 million | Q1 2021: $266.92 million | Q2 2021: $98.90 million | Q3 2021: $159.27 million | Q4 2021: $150.86 million | Q1 2022: $201.93 million | Q2 2022: $12.79 million | Q3 2022: $352.0 thousand | Q4 2022: -$36.55 million | Q1 2023: -$24.82 million | Q2 2023: -$19.80 million | Q3 2023: $214.0 thousand | Q1 2024: -$21.80 million | Q2 2024: -$18.91 million | Q3 2024: -$17.08 million | Q1 2025: -$19.80 million | Q2 2025: -$19.71 million | Q3 2025: -$15.35 million.
- Over the full 12 years of available data (2014 to 2025), Fulgent Genetics, Inc.'s Operating Income Loss has declined by 9,101.6%.
- Historical annual values: Fiscal year 2025: -$91.10 million | Fiscal year 2024: -$73.92 million | Fiscal year 2023: -$195.53 million | Fiscal year 2022: $178.53 million | Fiscal year 2021: $675.95 million | Fiscal year 2020: $290.16 million | Fiscal year 2019: -$428.0 thousand | Fiscal year 2018: -$5.07 million | Fiscal year 2017: -$3.48 million | Fiscal year 2016: $918.0 thousand | Fiscal year 2015: -$5.01 million | Fiscal year 2014: -$990.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: